News | November 11, 2024
Aurobindo Pharma Q2 FY25 net profit up 8.6% at Rs. 817 Cr
Growth markets revenue increased by 44 YoY to Rs. 812 crore
Growth markets revenue increased by 44 YoY to Rs. 812 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Spread over 1.26 lakh sq ft building, the super-specialty eye hospital will perform 30,000 free eye surgeries annually for economically weaker sections
Indoco is comprehensively working on the remedial action plan
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Rad-Sure blood irradiation indicators are FDA 510 (k) cleared medical devices that offer positive visual verification of irradiation at the minimum specified dose
Revenue from Operations increased by 10.5% YoY to Rs. 7,567 crore with growth across the businesses
Report highlights significant improvements in adolescent well-being in India
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Subscribe To Our Newsletter & Stay Updated
